These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7601416)

  • 1. Metabolism of cysteinyl leukotrienes in the perfused rat liver: the influence of endotoxin pretreatment and the cellular hydration state.
    Wettstein M; Noé B; Häussinger D
    Hepatology; 1995 Jul; 22(1):235-40. PubMed ID: 7601416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hypoxia on nitric oxide formation and leukotriene metabolism in the perfused rat liver].
    Wettstein M; Häussinger D
    Zentralbl Chir; 1994; 119(5):328-33. PubMed ID: 7517604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of sinusoidal uptake and biliary excretion of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1990 Jul; 191(1):251-5. PubMed ID: 2165907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and CCl4-induced liver injury, but not acidosis, impair metabolism of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Hepatology; 1990 May; 11(5):866-73. PubMed ID: 2161395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different pathomechanisms of altered biliary leukotriene C4 elimination in isolated perfused rat livers.
    Enderle GJ; Delabar U; Krell H
    Biochem Pharmacol; 1995 Jan; 49(3):297-304. PubMed ID: 7857316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog.
    Pfeifer CA; Bottoms GD; Johnson MA; Fessler J
    Circ Shock; 1991 Feb; 33(2):68-83. PubMed ID: 1675594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography.
    Guhlmann A; Krauss K; Oberdorfer F; Siegel T; Scheuber PH; Müller J; Csuk-Glänzer B; Ziegler S; Ostertag H; Keppler D
    Hepatology; 1995 Jun; 21(6):1568-75. PubMed ID: 7768501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver.
    Cincu RN; Rodríguez-Ortigosa CM; Vesperinas I; Quiroga J; Prieto J
    Hepatology; 1997 Aug; 26(2):330-5. PubMed ID: 9252142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene C4 metabolism by hepatoma cells and liver.
    Keppler D; Huber M; Weckbecker G; Hagmann W; Denzlinger C; Guhlmann A
    Adv Enzyme Regul; 1987; 26():211-24. PubMed ID: 2890280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of bile flow and inhibition of biliary secretion of taurocholate and leukotriene C4 in thioacetamide-induced liver fibrosis.
    Müller D; Dietze E; Dargel R; Krell H
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():16-9. PubMed ID: 7483705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
    Baumgartner U; Hardison WG; Miyai K
    Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitized liver represents a rich source of endogenous leukotrienes.
    Hagmann W; Kaiser I; Jakschik BA
    Hepatology; 1991 Mar; 13(3):482-8. PubMed ID: 1999319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat.
    Foster A; Letts G; Charleson S; Fitzsimmons B; Blacklock B; Rokach J
    J Immunol; 1988 Nov; 141(10):3544-50. PubMed ID: 2846689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile ductular proliferation and altered leukotriene elimination in thioacetamide-induced fibrosis of rat liver.
    Müller D; Enderle GJ; Löw O; Dietze E; Krell H
    J Hepatol; 1996 Oct; 25(4):547-53. PubMed ID: 8912155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of [3H]-methylcholanthrene in the perfused rat liver.
    Takahashi G; Shah H; Weinhouse S
    Cancer Res; 1977 Feb; 37(2):369-75. PubMed ID: 188544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene C4 metabolism during its action on glucose and lactate balance and flow in perfused rat liver.
    Iwai M; Hagmann W; Keppler D; Jungermann K
    Biol Chem Hoppe Seyler; 1988 Oct; 369(10):1131-6. PubMed ID: 3242543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum complement mediates endotoxin-induced cysteinyl leukotriene formation in rats in vivo.
    Jaeschke H; Raftery MJ; Justesen U; Gaskell SJ
    Am J Physiol; 1992 Dec; 263(6 Pt 1):G947-52. PubMed ID: 1476201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion.
    Huber M; Guhlmann A; Jansen PL; Keppler D
    Hepatology; 1987; 7(2):224-8. PubMed ID: 3030916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
    Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
    Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.